Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Edmonds

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Annals of the Rheumatic Diseases|January 1, 1986
Rabbit antisera to cross-reactive organisms--where's the problemA F Geczy, L I Upfold, J S Sullivan, et al.
Annals of the Rheumatic Diseases|February 1, 1987
HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptionsA F Geczy, J K Prendergast, J S Sullivan, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trialsM Boers, P Tugwell, D T Felson, et al.
The Journal of Rheumatology|January 1, 1988
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritisG D Champion, D R Cairns, D Bieri, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Annals of the Rheumatic Diseases|January 1, 1986
Rabbit antisera to cross-reactive organisms--where's the problemA F Geczy, L I Upfold, J S Sullivan, et al.
Annals of the Rheumatic Diseases|February 1, 1987
HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptionsA F Geczy, J K Prendergast, J S Sullivan, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trialsM Boers, P Tugwell, D T Felson, et al.
The Journal of Rheumatology|January 1, 1988
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritisG D Champion, D R Cairns, D Bieri, et al.
Pageof 5